The companies will recruit and track a cohort of women to study environmental, genetic, and lifestyle factors that may contribute to fertility outcomes.
Celmatix's Fertilome test aims to give women genetic insight into their fertility.
Trial studying the use of next-generation sequencing-based pre-implantation genetic screening has its first birth, the Guardian reports.
Loci identified in a genome-wide association study of women with spontaneous fraternal twin birth offers clues to the hormonal processes behind this propensity.
The test uses Illumina arrays to measure genome-wide sperm DNA methylation patterns in order to predict male fertility status and resulting embryo quality.
They will work to accelerate the launch of Celmatix's infertility genetics tests and develop early screening tests for declining ovarian function.
Researchers have found an accumulation of mutations in the genome of the African cheetah that may contribute to its low reproductive success.
Researchers in Saudi Arabia sequenced the exomes of women having trouble conceiving and found a mutation that appears to halt early embryonic development.
A test examining mitochondrial DNA levels appears to increase pregnancy rates at fertility clinics, the Guardian reports.
The Personalized Reproductive Medicine Initiative will investigate how an individual's genetic signature and personalized metrics affect overall fertility.
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.
Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.